Orgenesis Company

Orgenesis is a development stage company with a novel therapeutic approach in the treatment of diabetes by correcting malfunctioning organs with new functional tissues created from the patient’s own existing organs. Orgenesis employs a molecular and cellular approach directed at converting liver cells into functional insulin-producing cells as a treatment for diabetes. This new therapeutic approach is called Autologous Insulin Producing (AIP) cell transplantation.
Technology:
Regenerative Medicine
Industry:
Regenerative Medicine
Headquarters:
Tel Aviv, Israel
Founded Date:
6-30
Employees Number:
Undisclosed
Funding Status:
N/A
Register and Claim Ownership